CMMB – chemomab therapeutics ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Chemomab Therapeutics Ltd. (NASDAQ: CMMB) is now covered by analysts at Maxim Group. They set a "buy" rating and a $4.00 price target on the stock.
Chemomab Therapeutics Ltd. Sponsored ADR (CMMB) Now Trades Above Golden Cross: Time to Buy? [Yahoo! Finance]
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Chemomab Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
Chemomab Therapeutics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule [Yahoo! Finance]
Form 6-K Chemomab Therapeutics For: May 09
Form 6-K Chemomab Therapeutics For: May 08
Form 6-K Chemomab Therapeutics For: May 03
Form 20-F Chemomab Therapeutics For: Dec 31
Form SC 13D/A Chemomab Therapeutics Filed by: OrbiMed Israel BioFund GP Limited Partnership
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.